NasdaqCM - Nasdaq Real Time Price
USD
20/20 Biolabs, Inc. (AIDX)
0.2350
+0.0231
(+10.90%)
At close: November 2 at 4:00:02 PM EST
0.2257
-0.0093
(-3.96%)
After hours: November 2 at 4:06:54 PM EST
Loading chart for AIDX
Chart does not reflect overnight price.
- Previous Close
0.2119 - Open
0.2130 - Bid 0.6100 x 100
- Ask 1.0000 x 100
- Day's Range
0.2128 - 0.2398 - 52 Week Range
0.2100 - 50.0000 - Volume
60,658 - Avg. Volume
102,142 - Market Cap (intraday)
3.001M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-0.7500 - Earnings Date --
- Forward Dividend & Yield -- (0.00%)
- Ex-Dividend Date --
- 1y Target Est
5.00
Recent News
View MorePerformance Overview
Trailing total returns as of 11/2/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
AIDX
99.53%
S&P 500 (^GSPC)
10.17%
1-Year Return
AIDX
99.53%
S&P 500 (^GSPC)
10.25%
3-Year Return
AIDX
99.53%
S&P 500 (^GSPC)
74.66%
5-Year Return
AIDX
99.53%
S&P 500 (^GSPC)
62.86%
Earnings Trends
View MoreAnalyst Insights
View MoreStatistics
View MoreValuation Measures
-
Market Cap
-
Enterprise Value
-
Trailing P/E
-
Forward P/E
-
PEG Ratio (current)
-
Price/Sales (ttm)
-
Price/Book (mrq)
-
Enterprise Value/Revenue
-
Enterprise Value/EBITDA
Financial Highlights
Profitability and Income Statement
-
Profit Margin
-285.00%
-
Return on Assets (ttm)
-62.37%
-
Return on Equity (ttm)
-331.22%
-
Revenue (ttm)
2.04M
-
Net Income Avi to Common (ttm)
-7.12M
-
Diluted EPS (ttm)
-0.7500
Balance Sheet and Cash Flow
-
Total Cash (mrq)
4.55M
-
Total Debt/Equity (mrq)
18.12%
-
Levered Free Cash Flow (ttm)
-805.68k
